Jessica Fye
Stock Analyst at J.P. Morgan
(4.54)
# 1,106
Out of 4,609 analysts
587
Total ratings
55.3%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $125 → $118 | $99.89 | +18.13% | 14 | Aug 6, 2026 | |
| BNTX BioNTech SE | Maintained: Hold | $120 → $92 | $92.67 | -0.72% | 30 | Aug 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $375 | $216.99 | +72.82% | 28 | Aug 4, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $276 | $257.69 | +7.11% | 33 | Aug 4, 2026 | |
| MRNA Moderna | Maintained: Sell | $40 | $58.38 | -31.48% | 23 | Aug 4, 2026 | |
| IONS Ionis Pharmaceuticals | Rated: Buy | $72 → $76 | $55.63 | +36.62% | 32 | Aug 3, 2026 | |
| INCY Incyte | Rated: Hold | $110 → $120 | $120.33 | -0.27% | 26 | Jul 30, 2026 | |
| ALKS Alkermes | Rated: Hold | $60 → $61 | $49.19 | +24.02% | 15 | Jul 29, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $685 → $687 | $531.71 | +29.21% | 34 | Jul 23, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $425 | $345.34 | +23.07% | 14 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $179 | $129.58 | +38.14% | 27 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $33 | $24.15 | +36.65% | 2 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $13 → $12 | $9.44 | +27.12% | 19 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 → $17 | $16.26 | +4.55% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 → $29 | $24.59 | +17.93% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $76 → $35 | $20.46 | +71.07% | 13 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $254.51 | - | 48 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $30 | $75.69 | -60.36% | 31 | Nov 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $25 | $32.16 | -22.26% | 17 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $63.47 | - | 16 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 → $65 | $101.04 | -35.67% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $14.32 | -30.14% | 10 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $51.86 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $517 → $530 | $493.32 | +7.44% | 21 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $52 | $83.91 | -38.03% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.08 | n/a | 3 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $33.59 | n/a | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $5.04 | n/a | 13 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $14 | $23.71 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $2.41 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $19 | $1.87 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.6619 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $107.88 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $66 | $151.19 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $7.99 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $13.66 | n/a | 4 | Feb 8, 2018 |
Mirum Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $125 → $118
Current: $99.89
Upside: +18.13%
BioNTech SE
Aug 6, 2026
Maintained: Hold
Price Target: $120 → $92
Current: $92.67
Upside: -0.72%
Alnylam Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $375
Current: $216.99
Upside: +72.82%
Jazz Pharmaceuticals
Aug 4, 2026
Rated: Buy
Price Target: $276
Current: $257.69
Upside: +7.11%
Moderna
Aug 4, 2026
Maintained: Sell
Price Target: $40
Current: $58.38
Upside: -31.48%
Ionis Pharmaceuticals
Aug 3, 2026
Rated: Buy
Price Target: $72 → $76
Current: $55.63
Upside: +36.62%
Incyte
Jul 30, 2026
Rated: Hold
Price Target: $110 → $120
Current: $120.33
Upside: -0.27%
Alkermes
Jul 29, 2026
Rated: Hold
Price Target: $60 → $61
Current: $49.19
Upside: +24.02%
United Therapeutics
Jul 23, 2026
Maintained: Buy
Price Target: $685 → $687
Current: $531.71
Upside: +29.21%
BeOne Medicines AG
Jul 23, 2026
Maintained: Buy
Price Target: $425
Current: $345.34
Upside: +23.07%
Jul 22, 2026
Reiterated: Buy
Price Target: $179
Current: $129.58
Upside: +38.14%
Jul 14, 2026
Rated: Buy
Price Target: $30 → $33
Current: $24.15
Upside: +36.65%
Jul 13, 2026
Initiated Coverage: Hold
Price Target: $13 → $12
Current: $9.44
Upside: +27.12%
Jul 13, 2026
Maintained: Hold
Price Target: $23 → $17
Current: $16.26
Upside: +4.55%
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $26 → $29
Current: $24.59
Upside: +17.93%
Jul 13, 2026
Initiated Coverage: Hold
Price Target: $76 → $35
Current: $20.46
Upside: +71.07%
Jun 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $254.51
Upside: -
Nov 9, 2025
Maintained: Sell
Price Target: $30
Current: $75.69
Upside: -60.36%
Nov 3, 2025
Maintained: Hold
Price Target: $15 → $25
Current: $32.16
Upside: -22.26%
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $63.47
Upside: -
Oct 27, 2025
Maintained: Hold
Price Target: $63 → $65
Current: $101.04
Upside: -35.67%
Oct 17, 2025
Maintained: Sell
Price Target: $10
Current: $14.32
Upside: -30.14%
Oct 13, 2025
Maintained: Buy
Price Target: n/a
Current: $51.86
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: $517 → $530
Current: $493.32
Upside: +7.44%
Sep 24, 2025
Reiterated: Buy
Price Target: $53 → $52
Current: $83.91
Upside: -38.03%
Jun 16, 2025
Maintained: Buy
Price Target: n/a
Current: $66.08
Upside: n/a
Apr 11, 2025
Maintained: Buy
Price Target: $50
Current: $33.59
Upside: n/a
Nov 20, 2023
Initiated Coverage: Sell
Price Target: n/a
Current: $5.04
Upside: n/a
Jun 7, 2022
Maintained: Hold
Price Target: $18 → $14
Current: $23.71
Upside: n/a
Apr 7, 2022
Maintained: Hold
Price Target: $7 → $5
Current: $2.41
Upside: n/a
Mar 14, 2022
Maintained: Buy
Price Target: $20 → $19
Current: $1.87
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.6619
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $107.88
Upside: n/a
Apr 6, 2020
Maintained: Hold
Price Target: $94 → $66
Current: $151.19
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $7.99
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $13.66
Upside: n/a